How secret deals could keep a COVID-19 drug out of reach for millions
Wednesday, July 1, 2020 - 20:00
in Health & Medicine
Activists say Gilead Sciences has signed agreements that could prevent the antiviral drug remdesivir from reaching dozens of hard-hit countries.